[an error occurred while processing this directive]
Reviews

Identification of disease targets for precision medicine by integrative analysis of multi-omics data

Expand
  • 1. CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China;
    2. University of Chinese Academy of Sciences, Beijing 100049, China

Received date: 2015-02-02

  Revised date: 2015-03-31

  Online published: 2015-07-20

Abstract

With the development and improvement of high-throughput sequencing technologies, the acquisition and processing approaches of various biological omics data on different levels are becoming more mature. Despite several new disease-associated factors have been discovered based on single omics data analysis, identification of disease targets by integrative analysis of multi-omics data is still growing. Since life is a complex regulatory system in which the regulation of gene mutations, epigenetic alterations, abnormal gene expression as well as anomalous variations in signal pathway are related with the occurrence and development of diseases, it is obvious that finding therapeutic factors using single omics data analysis has its limitation. Systematical studies of clinical and pathological mechanisms and identification of optimal therapeutic targets through integrative analysis of multi-omics data from different levels and resources have become an important research direction of precision medicine, which would provide innovative perspectives on disease study and new theoretical basis for early diagnosis, personalized treatment and medicine guide. In this review, we introduce new technologies and research progresses in screening therapeutic targets using systematic omics such as genomics, transcriptomics and epigenomics, and also discusse new strategies and advantages of integrative analysis among them.

Cite this article

Bingbing Xie, Yadong Yang, Nan Ding, Xiangdong Fang . Identification of disease targets for precision medicine by integrative analysis of multi-omics data[J]. Hereditas(Beijing), 2015 , 37(7) : 655 -663 . DOI: 10.16288/j.yczz.15-061

References

[1] Koboldt DC, Steinberg KM, Larson DE, Wilson RK, Mardis ER. The next-generation sequencing revolution and its impact on genomics. Cell , 2013, 155(1): 27-38.
[2] Li S, Tighe SW, Nicolet CM, Grove D, Levy S, Farmerie W, Viale A, Wright C, Schweitzer PA, Gao Y, Kim D, Boland J, Hicks B, Kim R, Chhangawala S, Jafari N, Raghavachari N, Gandara J, Garcia-Reyero N, Hendrickson C, Roberson D, Rosenfeld JA, Smith T, Underwood JG, Wang M, Zumbo P, Baldwin DA, Grills GS, Mason CE. Multi-platform assessment of transcriptome profiling using RNA-seq in the ABRF next-generation sequencing study. Nat Biotechnol , 2014, 32(9): 915-925.
[3] Rivera CM, Ren B. Mapping human epigenomes. Cell , 2013, 155(1): 39-55.
[4] The International HapMap 3 Consortium. Integrating common and rare genetic variation in diverse human populations. Nature , 2010, 467(7311): 52-58.
[5] 丁楠, 渠鸿竹, 方向东. ENCODE计划和功能基因组研究. 遗传, 2014, 36(3): 237-247.
[6] Qu HZ, Fang XD. A brief review on the Human Encyclopedia of DNA Elements (ENCODE) project. Genomics Proteomics Bioinformatics , 2013, 11(3): 135-141.
[7] The 10000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature , 2012, 491(7422): 56-65.
[8] Zhu XF, He FH, Zeng HM, Ling SP, Chen AL, Wang YQ, Yan XM, Wei W, Pang YK, Cheng H, Hua CL, Zhang Y, Yang XJ, Lu X, Cao LH, Hao LT, Dong LL, Zou W, Wu J, Li X, Zheng S, Yan J, Zhou J, Zhang LX, Mi SL, Wang XJ, Zhang L, Zou Y, Chen YM, Geng Z, Wang JM, Zhou JF, Liu X, Wang JX, Yuan WP, Huang G, Cheng T, Wang QF. Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet , 2014, 46(3): 287-293.
[9] Zhang WJ, Gao YJ, Li PX, Shi ZB, Guo T, Li F, Han XK, Feng Y, Zheng C, Wang ZY, Li FM, Chen HQ, Zhou ZC, Zhang L, Ji HB. VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res , 2014, 24(3): 331-343.
[10] Muers M. RNA: Genome-wide views of long non-coding RNAs. Nat Rev Genet , 2011, 12(11): 742.
[11] 李语丽, 于军, 宋述慧. RNA中6-甲基腺嘌呤的研究进展. 遗传,2013, 35(12): 1340-1351.
[12] Zhang XO, Wang HB, Zhang Y, Lu XH, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell , 2014, 159(1): 134-147.
[13] Chu C, Qu K, Zhong FL, Artandi SE, Chang HY. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell , 2011, 44(4): 667-678.
[14] Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3 ' UTRs and near stop codons. Cell , 2012, 149(7): 1635-1646.
[15] Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L, Parkinson H. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucl Acids Res , 2014, 42(D1): D1001-D1006.
[16] Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C, Newsham I, Reid JG, Fink JK, Morgan MB, Gingras MC, Muzny DM, Hoang LD, Yousaf S, Lupski JR, Gibbs RA. Whole-genome sequencing for optimized patient management. Sci Transl Med , 2011, 3(87): 87re3.
[17] Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet , 2011, 12(11): 745-755.
[18] Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER Jr, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet , 2014, 46(2): 161-165.
[19] Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lun
Outlines

/